Reference
Holdford D, et al. Indirect Economic Burden of Sickle Cell Disease. Value in Health 24: 1095-1101, No. 8, Aug 2021. Available from: URL: http://doi.org/10.1016/j.jval.2021.02.014
Rights and permissions
About this article
Cite this article
Indirect costs of sickle cell disease high in USA. PharmacoEcon Outcomes News 885, 13 (2021). https://doi.org/10.1007/s40274-021-07955-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-07955-x